<p>Fold-increase indicates the ratio of binding affinities between the mutants and wild-type decoy receptor.</p
<p>Plotted are the log2 ratios of the protein levels in the mutants over in wild-type. Cluster 1 inc...
<p>The scFv-Fc mutants were expressed in Expi293 cells to determine their apparent binding affinitie...
<p>Binding affinities of dodecanol and its analogs to rGmolGOBP2 wild-type and mutants.</p
<p>Binding affinities (K<sub>D</sub>) of the single mutants for MD2 were measured from the associati...
<p><b>Bold</b> denotes measured affinity improvements, or specificity changes, greater than 3-fold.<...
<p>(A) Crystal structure of the decoy receptor in complex with MD2 (PDB ID 2Z65). The decoy receptor...
<p>Binding affinities (<i>K</i><sub>d</sub>) of Ang II and R compounds to AT<sub>1</sub> wild-type (...
<p>Shown is a scatter plot of the experimentally measured relative binding affinities of double and ...
<p>IC<sub>50</sub> values are plotted as cognate wild type and variant pairs, where lower IC<sub>50<...
<p><b>A and B</b>, respectively show dose-dependent direct glycan array binding of mFC: LS and mCC: ...
<p>Binding affinities (<i>K</i><sub>d</sub>) of Ang II, olmesartan, R239470 and R794847 to AT<sub>1<...
<p>Data represent ratios of ELISA results where MAb binding to envelope proteins with the mutations ...
<p>Binding affinities (<i>K</i><sub>d</sub>) of Ang II, olmesartan, R239470 and R794847 to AT<sub>1<...
<p>(A) Superimposed backbone structure of F63W mutant/MD2 complex into the wild-type decoy receptor/...
Log2 fold change values are shown for each adad1 mutant line compared to their wild-type siblings fo...
<p>Plotted are the log2 ratios of the protein levels in the mutants over in wild-type. Cluster 1 inc...
<p>The scFv-Fc mutants were expressed in Expi293 cells to determine their apparent binding affinitie...
<p>Binding affinities of dodecanol and its analogs to rGmolGOBP2 wild-type and mutants.</p
<p>Binding affinities (K<sub>D</sub>) of the single mutants for MD2 were measured from the associati...
<p><b>Bold</b> denotes measured affinity improvements, or specificity changes, greater than 3-fold.<...
<p>(A) Crystal structure of the decoy receptor in complex with MD2 (PDB ID 2Z65). The decoy receptor...
<p>Binding affinities (<i>K</i><sub>d</sub>) of Ang II and R compounds to AT<sub>1</sub> wild-type (...
<p>Shown is a scatter plot of the experimentally measured relative binding affinities of double and ...
<p>IC<sub>50</sub> values are plotted as cognate wild type and variant pairs, where lower IC<sub>50<...
<p><b>A and B</b>, respectively show dose-dependent direct glycan array binding of mFC: LS and mCC: ...
<p>Binding affinities (<i>K</i><sub>d</sub>) of Ang II, olmesartan, R239470 and R794847 to AT<sub>1<...
<p>Data represent ratios of ELISA results where MAb binding to envelope proteins with the mutations ...
<p>Binding affinities (<i>K</i><sub>d</sub>) of Ang II, olmesartan, R239470 and R794847 to AT<sub>1<...
<p>(A) Superimposed backbone structure of F63W mutant/MD2 complex into the wild-type decoy receptor/...
Log2 fold change values are shown for each adad1 mutant line compared to their wild-type siblings fo...
<p>Plotted are the log2 ratios of the protein levels in the mutants over in wild-type. Cluster 1 inc...
<p>The scFv-Fc mutants were expressed in Expi293 cells to determine their apparent binding affinitie...
<p>Binding affinities of dodecanol and its analogs to rGmolGOBP2 wild-type and mutants.</p
DOI
Add to ORKG